June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
E-cadherin and Par 3 expression in conjunctival melanoma and squamous cell carcinoma
Author Affiliations & Notes
  • Rebecca Schmidt
    Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany
  • Claus Cursiefen
    Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany
    University of Cologne Center for Molecular Medicine Cologne, Cologne, Nordrhein-Westfalen, Germany
  • Ludwig M Heindl
    Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany
    Center for Integrated Oncology (CIO) Aachen-Bonn-Cologne-Duesseldorf, Germany
  • Simona Schlereth
    Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany
    University of Cologne Center for Molecular Medicine Cologne, Cologne, Nordrhein-Westfalen, Germany
  • Footnotes
    Commercial Relationships   Rebecca Schmidt, None; Claus Cursiefen, None; Ludwig Heindl, None; Simona Schlereth, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 2849. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rebecca Schmidt, Claus Cursiefen, Ludwig M Heindl, Simona Schlereth; E-cadherin and Par 3 expression in conjunctival melanoma and squamous cell carcinoma. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2849.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Cell-cell adhesion and cell-polarity protein complexes coordinate crucial processes that ensure epithelial integrity. Among these, the cell-cell adhesion molecule E-cadherin and the polarity protein PAR3 serve import functions in epithelial tissues and its loss is associated with dermal melanoma progression and elevated metastasis. The role of PAR3 or E-cadherin in conjunctival melanoma (CM) and in conjunctival squamous cell carcinoma (SCC) remains open. This study aims to analyze the expression of these central markers for cell-cell adhesion and cyto-architecture to gain insight into molecular changes during ocular surface tumor progression.

Methods : The expression of epithelial PAR3 and E-cadherin in 32 patients with human SCC, CM and the corresponding precancerous lesions have been analyzed immunohistochemically in formalin-fixed paraffin-embedded tissues.

Results : In SCC and its precancerous lesions conjunctival intraepithelial neoplasia (CIN) I-III, E-cadherin expression was significantly decreased compared to controls. Melanocytes and keratinocytes in healthy conjunctiva were E-cadherin positive. In CM E-cadherin expression was reduced. Conjunctival carcinomas switch their E-cadherin expression from extra- to intracellular. PAR3 was statistically significant decreased expressed in the epithelium of CIN I-III, SCC, CM, and the melanoma in situ probes compared to controls.

Conclusions : In CIN, SCC, and CM a reduction of the cell-cell adhesion molecule E-cadherin and the polarity protein PAR3 is seen. This indicates that during carcinogenesis even the premalignant lesions lose expression of these markers. Loss of PAR3 and extracellular E-cadherin expression might be used as additional diagnostic tools to separate premalignant from benign lesions in the future and as a potential therapeutic target.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×